Infusion Pumps: Technology and Market 2012-2022
NEW YORK, April 2, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Infusion Pumps: Technology and Market 2012-2022
http://www.reportlinker.com/p0819457/Infusion-Pumps-Technology-and-Market-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
Report Details
Our new report Infusion Pumps: Technology and Market 2012-2022 covers the trends in the infusion pumps market, a promising segment of the drug delivery sector. The traditional gravity controlled infusion pumps have been used extensively. The electronic infusion pumps have also been available in the market since long, but only beginning to see increased adoption. The use of infusion pumps is advantageous for the healthcare providers as well as the patients specifically for conditions such as diabetes, delivery of analgesics in cancer patients or post-surgery, delivery of chemotherapy drugs and enteral feeding in patients with feeding disorders. As the technology becomes more advanced, the infusion pumps are becoming smaller in size, wireless, and more convenient to use. Combined with the ability of the infusion pumps to deliver precisely measured dose are the right intervals, the infusion pumps allow the patients to carry out their normal activities, and reduce the hospital stay and visits. According to our latest pharma report - the global infusion pumps market will be worth $9.5bn by 2016.
Infusion Pumps: Technology and Market 2012-2022 report forecasts the size and value of leading national/regional markets: North America, Europe, Japan, India and China. For each of these, visiongain identifies prevailing trends and strategies that will steer this emerging technology over the forecast period. The use of infusion pumps is still more prevalent in the developed regions of North America and Europe, essentially owing to the fact that the infusion pump technology is expensive when compared to the competing technologies. The cost of insulin pumps is covered under Medicare in the US and through private insurance in Canada. However, there are huge opportunities for infusion pump manufacturers in the developing economies of India and China where the use of electronic infusion pumps is limited at present. The report discusses the future technological development that will make the infusion pumps more attractive to the patients and drive their adoption.
Infusion Pumps: Technology and Market 2012-2022 also examines the challenges facing the sector critically, including the high cost and safety issues. The report is developed through a comprehensive review of information sources, both primary and secondary. In our report you find sales forecasts, growth rates and market shares. You also receive qualitative analyses and a review of companies and leading products.
Why you should buy Infusion Pumps: Technology and Market 2012-2022
In this report, you will receive the following benefits in particular:
• You will receive our assessment of the current market for infusion pumps, with respect to the leading segments, products, companies and national markets
• You will discover sales trends for the overall infusion pumps market from 2011 to 2022 - seeing where commercial growth will occur
• You will discover sales trends for the main segments - insulin pumps and enteral feeding pumps - from 2011 to 2022, with detailed discussions of market potential
• You will receive sales forecasts for leading national/regional markets (North America, Japan, Europe, India and China), with informed discussion
• You will assess leading manufacturers and products in the leading segments of the infusion pumps market, with information on the pipeline products
• You will examine the strengths, weaknesses, opportunities and threats (SWOT analysis) facing the infusion pumps market from 2012 onwards
• You will be able to investigate competition and opportunities influencing the infusion pumps technology for drug delivery from 2012 onwards
• You will see what will stimulate and restrain the market from 2012
• You will discover the unmet needs in the market, driving the growth from 2012 onwards.
You can order this report today
Anybody with an interest in the infusion pumps market should gain valuable information and insight from this new study by Visiongain, which analyses one of the most important sub-sectors of the drug delivery industry. The infusion pumps market is undergoing many important shifts. You can stay ahead by ordering this report today.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Table of Contents
1. Executive Summary
1.1 Infusion Pumps Market Highlights
1.2 Overview of Chapter Content
1.3 Research and Analysis Method
1.4 Glossary of Terms Relating to Infusion Pumps
2. Introduction
2.1 What is an Infusion Pump?
2.2 Types of Infusion
2.3 Types of Pumps
2.3.1 Gravity Controlled Pumps
2.3.2 Positive Displacement Pumps
2.3.2.1 Drip Rate Pumps
2.3.2.2 Volumetric Pumps
2.3.2.3 Syringe Pumps
2.3.2.4 Multi-Channel Pumps
2.3.2.5 Ambulatory Pumps
2.4 History of Infusion Pumps
2.5 What Clinical Settings Will Infusion Pumps Be Useful?
2.5.1 Infusion Pumps for Diabetes
2.5.2 Infusion Pumps for Chemotherapy
2.5.3 Infusion Pumps for Analgesia
2.5.4 Infusion Pumps for Enteral Feeding
2.5.5 Other Uses for Infusion Pumps
2.6 Advantages and Disadvantages of Infusion Pumps
2.7 Regulation of the Infusion Pump Market
2.7.1 The US Regulation System
2.7.2 The European Regulatory System
2.7.2.1 Post Marketing Surveillance in the EU
2.8 Infusion Pump Market
2.8.1 Infusion Pump Market Definition
3. The Infusion Pumps Market, 2010-2022
3.1 The Infusion Pumps Market Overview
3.2 The Infusion Pumps Market by Segment and Region, 2010
3.2.1 The Infusion Pumps Market: Segment Breakdown, 2010
3.2.2 The Infusion Pumps Market: Regional Breakdown, 2010
3.2.3 Regional Market Breakdown, 2010
3.2.3.1 The North American Market
3.2.3.2 The EU Market
3.2.3.3 The Japanese Market
3.2.3.4 The Chinese Market
3.2.3.5 The Indian Market
3.3 The Infusion Pumps Market Forecast, 2011-2022
3.3.1 The Infusion Pumps Market Forecast, 2011-2016
3.3.2 The Infusion Pumps Market Forecast, 2016-2022
3.4 The Infusion Pumps Market Forecasts by Region, 2011-2022
3.4.1 The NA, EU and Japanese Infusion Pumps Market Forecasts, 2011-2022
3.4.1.1 The North American Infusion Pumps Market Forecast, 2011-2022
3.4.1.2 The EU Infusion Pumps Market Forecast, 2011-2022
3.4.1.3 The Japanese Infusion Pumps Market Forecast, 2011-2022
3.4.2 The Chinese and Indian Infusion Pumps Market Forecast, 2011-2022
3.4.2.1 The Chinese Infusion Pumps Market Forecast, 2011-2022
3.4.2.2 The Indian Infusion Pumps Market Forecast, 2011-2022
3.5 Concluding Remarks
4. Insulin Pumps
4.1 Introduction to Insulin Pumps
4.1.1 The Dosing of Insulin in Insulin Pumps
4.1.1.1 Bolus Infusion
4.1.1.2 Basal Infusion
4.1.2 The Advantages and Disadvantages of Insulin Pumps
4.1.3 Human Insulins and Analogues Primarily Used In Insulin Pumps
4.2 Current State of The Insulin Infusion Pump Market
4.2.1 Leading Products in the Insulin Pump Market, 2012
4.2.1.1 OmniPod (Insulet Corporation)
4.2.1.2 Minimed Paradigm Revel (Medtronic)
4.2.1.3 OneTouch Ping (Animas Corporation)
4.2.1.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
4.2.1.5 Deltec Cozmo Insulin Pump (Smith Medical)
4.2.1.6 SpringZone (D. Medical Industries)
4.2.1.7 Other Notable Products
4.2.2 Leading National Markets for Insulin Pump, 2010
4.3 The Insulin Pump Market Forecast
4.3.1 The Insulin Pump Market Forecast, 2011-2016
4.3.2 The Insulin Pump Market Forecast, 2016-2022
4.3.3 Drivers and Restraints in the Insulin Pump Market, 2012-2022
4.4 The Insulin Pump Development Pipeline
4.4.1 V-Go (Valeritas)
4.4.2 Finesse Personal Insulin Patch (Calibra Medical)
4.4.3 SOLO Micropump (MEDINGO Ltd)
4.4.4 JewelPUMP (Debiotech)
4.4.5 t:slim (Tandem Diabetes Care)
4.4.6 Artificial Pancreas (Juvenile Diabetes Research Foundation)
4.4.7 DANA Diabecare IISG (SOOIL)
4.4.8 Next Generation OmniPod (Insulet Corporation)
4.4.9 Other Insulin Pumps in Development
4.5 Concluding Remarks
4.5.1 Security Risks with Insulin Pumps
5. Enteral Feeding Pumps
5.1 Introduction to Enteral Feeding Pumps
5.1.1 Clinical Settings That May Require Enteral Feeding
5.1.2 Advantages and Disadvantages of Enteral Feeding
5.1.3 Delivery of Enteral Feeding
5.1.3.1 Tube Placements Used in Enteral Feeding
5.1.4 Enteral Feeding at Home
5.1.4.1 Increasing Numbers of Patients Now Opt For Home Enteral Feeding
5.2 The Current State of the Enteral Feeding Pump Market
5.2.1 The Enteral Feeding Pump Market, Regional Breakdown, 2010
5.2.2 Products in the Enteral Feeding Pump Market, 2012
5.2.2.1 Companion Enteral Feeding Pump (Abbott Nutrition)
5.2.2.2 Patrol Enteral Feeding Pump (Abbott Nutrition)
5.2.2.3 Compat DualFlo Enteral Feeding Pump (Nestle Healthcare)
5.2.2.4 Sentinel Enteral Feeding Pump (ALCOR Scientific)
5.2.2.5 EnteraLite Infinity (Moog)
5.2.2.6 APPLIX Vision (Fresenius Kabi)
5.2.2.7 MiniFlo (Fresenius Kabi)
5.2.2.8 Nutricia FloCare Infinity Pump (Nutricia)
5.2.2.9 Sapphire TPN (Q Core Medical)
5.2.2.10 Kangaroo Joey Enteral Feeding Pump (Covidien)
5.2.2.11 Flexiflo Quantum Enteral Feeding Pump (Abbott Nutrition)
5.3 The Enteral Feeding Pump Market Forecast
5.3.1 The Global Enteral Feeding Pump Forecast, 2011-2016
5.3.2 The Global Enteral Feeding Pump Market Forecast, 2016-2022
5.3.3 Drivers and Restraints in The Global Enteral Feeding Pump Market
5.4 The Development Pipeline for Enteral Feeding Pumps, 2012
5.4.1 Enteral Nutrition Equipment (ART Healthcare)
5.5 Concluding Remarks
6. Other Infusion Pumps in the Market
6.1 Other Infusion Pumps Market Definition
6.1.1 The Other Infusion Pumps Market, 2010
6.1.1.1 The Other Infusion Pumps Market, Regional Breakdown, 2010
6.1.2 The Other Infusion Pumps Market Forecast, 2011-2022
6.2 Chemotherapy Pumps
6.2.1 Introduction to Chemotherapy
6.2.1.1 What is Chemotherapy?
6.2.1.2 Chemotherapy Dosing
6.2.2 Introduction to Chemotherapy Pumps
6.2.3 Advantages and Disadvantages of Chemotherapy Pumps
6.2.4 Leading Drugs in the Cancer Therapeutics Market, 2010
6.2.5 The Chemotherapy Pump Market, 2010
6.2.5.1 The Leading Products in The Chemotherapy Pump Market, 2010
6.2.5.1.1 Infusor Infusion Pump (Baxter)
6.2.5.1.2 CODMAN 3000 (DePuy, a subsidiary of Johnson & Johnson)
6.2.5.1.3 Purfusor Space (B.Braun)
6.2.5.1.4 Optima MS (Fresenius Kabi)
6.2.5.1.5 CADD Legacy-1 (Smith Medical)
6.2.5.1.6 Other Infusion Pumps for Chemotherapy
6.2.6 Drivers and Restraints for The Global Chemotherapy Pump Market, 2012-2022
6.2.7 The Chemotherapy Pump Pipeline
6.2.7.1 Metronomic Biofeedback Pump (Pharmaco-Kinesis Corporation)
6.2.8 Concluding Remarks
6.3 Patient Controlled Analgesia
6.3.1 Introduction to Patient Controlled Analgesia
6.3.1.1 What are PCA Pumps?
6.3.1.2 How Does a PCA Pump Work?
6.3.1.3 Clinical Settings Where PCA Pumps are Used
6.3.1.4 Advantages and Disadvantages of PCA Pumps
6.3.2 Leading Drugs in the Pain Relief Market
6.3.2.1 Narcotic Drugs
6.3.2.2 The Narcotics Drug Market, 2010-2022
6.3.3 The PCA Pump Market
6.3.3.1 The PCA Pump Market, 2010
6.3.3.2 Leading Products in the PCA Pump Market, 2010
6.3.3.2.1 LifeCare PCA with Hospira MedNet Software (Hospira)
6.3.3.2.2 GemStar Pain Management System (Hospira)
6.3.3.2.3 Alaris PCA (CareFusion)
6.3.3.2.4 PCA II (Baxter)
6.3.3.2.5 Curlin PainSmart IOD Pain Management System (B Braun)
6.3.3.2.6 CADD-Solaris Ambulatory Infusion Pump (Smith Medical)
6.3.4 Some More Marketed PCA Pumps, 2012
6.3.4.1 WalkMed PCA Pain Pump (WalkMed Infusion)
6.3.4.2 CODMAN 3000 (Codman & Shurtleff Inc, a subsidiary of DePuy)
6.3.4.3 Ambix ANAPlus (Fresenius Kabi)
6.3.4.4 Sapphire PCA (Q Core Medical)
6.3.5 PCA Infusion Pump Under Development, 2012
6.3.5.1 MIP (Debiotech)
6.3.6 Drivers and Restraints in the Global PCA Pump Market, 2012-2022
6.3.7 Concluding Remarks
7. Competing Technology
7.1 Drug Delivery Technologies
7.1.1 Introduction to Drug Delivery Technologies (DDT)
7.1.2 Types of Technologies for Drug Delivery
7.1.2.1 Sustained/Controlled Release Systems
7.1.2.2 Injection
7.1.2.3 Needle Free Injections
7.1.2.4 Pulmonary, Buccal and Nasal Delivery
7.1.2.5 Pills and Capsules
7.2 The Global Drug Delivery Market, 2010
7.2.1 Drug Delivery Technologies Market by Segment, 2010
7.2.2 Drug Delivery Technology Market by Region, 2010
7.3 Drug Delivery Technology Market Forecast, 2010-2022
7.4 Key Developments and Pipeline Products
7.5 Concluding Remarks
8. SWOT Analysis
8.1 Strengths
8.1.1 Pumpers Have Improved Quality of Life and Less Frequent Hospital Visits
8.1.2 Infusion Pumps Provide Highly Accurate Dosing at Regular Intervals
8.1.3 Infusion Pumps Can Be Used In a Wide Range of Clinical Indications
8.2 Weaknesses
8.2.1 Expensive Technology That May Restrain the Market
8.2.2 Regulatory Authorities are Reluctant to Take Risks
8.2.3 Pumps Are Cumbersome to Use and May Put off Potential Patients
8.3 Opportunities
8.3.1 Off-Patent Drugs Will Help To Drive The Market
8.3.2 Emerging Economies Will Help To Drive The Market
8.3.3 Technological Developments Will Help Drive The Market
8.4 Threats
8.4.1 Novel Drug Delivery Systems May be Cheaper and More Effective
8.4.2 Safety Concerns Regarding Infusion Pumps Will Act To Restrain The Market
8.4.3 Cost Effectiveness May Be Difficult to Prove
9. Conclusions
9.1 The Global Infusion Pump Market Will See Consistent Growth Over The Period 2010-2022
9.2 The Insulin Pump Market Will Remain The Largest Segment of The Market Throughout The Forecast Period
9.3 Safety Concerns Will Continue To Restrain The Market
Appendix A
Appendix B
Visiongain report evaluation form
List Of Tables
Table 2.1 Ideal Specifications of an Infusion Pump
Table 2.2 Specifications of Syringe Pumps
Table 2.3 Advantages and Disadvantages of Syringe Infusion Pumps
Table 2.4 Advantages and Disadvantages of Infusion Pumps
Table 3.1 Leading Segments in the Infusion Pumps Market by Sales ($bn), 2010
Table 3.2 The Infusion Pumps Market ($bn): Regional Breakdown, 2010
Table 3.3 The European Infusion Pumps Market ($bn) by Country, 2010
Table 3.4 The Global Infusion Pumps Market Forecast ($bn), 2010-2022
Table 3.5 The Global Infusion Pumps Market Forecast ($bn) by Region, 2010-2016
Table 3.6 The Global Infusion Pumps Market Forecast ($bn) by Region, 2016-2022
Table 3.7 Drivers and Restraints for the Chinese Infusion Pumps Market, 2012-2022
Table 3.8 Drivers and Restraints for the Indian Infusion Pumps Market, 2012-2022
Table 4.1 Advantages and Disadvantages of Insulin Pumps
Table 4.2 The Human Insulins and Analogues Leading Products by Sales ($bn), 2010
Table 4.3 The Leading Products in the Insulin Pump Market, 2012
Table 4.4 The Insulin Pumps Market ($m) by Region, 2010
Table 4.5 The Insulin Pump Market Forecast ($bn), 2010-2016
Table 4.6 The Insulin Pump Market Forecast ($bn), 2016-2022
Table 4.7 The Drivers and Restraints for the Global Insulin Pump Market, 2012-2022
Table 4.8 Development Pipeline for the Insulin Pump Market, 2012
Table 5.1 Types of Tubes Used in Enteral Feeding
Table 5.2 The Enteral Feeding Pump Market ($m): Regional Breakdown, 2010
Table 5.3 List of Some Products in the Enteral Feeding Pump Market, 2012
Table 5.4 The Global Enteral Feeding Pump Market Forecast ($bn), 2010-2016
Table 5.5 The Global Enteral Feeding Pump Market Forecast ($bn), 2016-2022
Table 5.6 The Drivers and Restraints For The Global Enteral Feeding Pump Market, 2012-2022
Table 6.1 The Other Infusion Pumps Market ($bn) by Region, 2010
Table 6.2 The Other Pump Market Sales Forecast ($bn), 2010-2022
Table 6.3 Advantages and Disadvantages of Chemotherapy Pumps
Table 6.4 The Top Nine Cancer Drug Sales ($bn), 2009 and 2010
Table 6.5 Top Nine Cancer Drugs 2009 and 2010: Key Facts
Table 6.6 Leading Products in The Chemotherapy Pump Market, 2010
Table 6.7 The Drivers and Restraints in the Global Chemotherapy Pump Market, 2012-2022
Table 6.8 Clinical Settings Where PCA Pumps are Used
Table 6.9 Advantages and Disadvantages of PCA Pumps
Table 6.10 The Global Narcotics Market Sales Forecast ($bn), 2010-2022
Table 6.11 The Leading Products in The PCA Pump Market, 2010
Table 6.12 Some More PCA Pumps in the Market, 2012
Table 6.13 The Drivers and Restraints For The Global PCA Pump Market, 2012-2022
Table 6.14 Late Stage R&D Pipeline for Narcotic Pain Relieving Drugs, 2012
Table 7.1 The Drug Delivery Market Sales ($bn) by Segment, 2010
Table 7.2 The Drug Delivery Technology Market Sales ($bn) by Country, 2010
Table 7.3 The Drug Delivery Technology Market Biannual Sales Forecast ($bn), 2010-2022
Table 7.4 The Key Developments and Pipeline Products in the Drug Delivery Market, 2012
Table 8.1 SWOT Analysis of the Infusion Pump Market, 2012
Table 8.2 Average Annual Costs Associated With Available Insulin Delivery Technologies, 2010
Table 8.3 The Infusion Pump and Related Product Recalls in The US, 2007-2011
Table 8.4 The Chinese and Indian Infusion Pump Market Forecast ($bn), 2010-2022
Table 9.1 The Global Infusion Pump Market ($bn) in 2010, 2016 and 2022
Table 9.2 The Infusion Pump Market Forecast ($bn) by Segment, 2010, 2016 and 2022
List Of Figures
Figure 3.1 The Infusion Pumps Market Share (%) by Segment, 2010
Figure 3.2 The Infusion Pumps Market Sales ($bn) by Segment, 2010
Figure 3.3 The Infusion Pumps Market Share (%) by Region, 2010
Figure 3.4 The Infusion Pumps Market ($bn) by Region, 2010
Figure 3.5 The European Infusion Pumps Market Share (%) by Country, 2010
Figure 3.6 The European Infusion Pumps Market ($bn) by Country, 2010
Figure 3.7 The Global Infusion Pumps Market Forecast ($bn), 2010-2022
Figure 3.8 The Global Infusion Pumps Market Forecast ($bn), 2010-2016
Figure 3.9 The North American Infusion Pumps Market Forecast ($bn), 2010-2016
Figure 3.10 The EU Infusion Pumps Market Forecast ($bn), 2010-2016
Figure 3.11 The Asian Infusion Pumps Market Forecasts ($bn), 2010-2016
Figure 3.12 The Global Infusion Pumps Market Forecast ($bn), 2016-2022
Figure 3.13 The North American Infusion Pumps Market Forecast ($bn), 2016-2022
Figure 3.14 The EU Infusion Pumps Market Forecast ($bn), 2016-2022
Figure 3.15 The Asian Infusion Pumps Market Forecasts ($bn), 2016-2022
Figure 4.1 The Leading Products in The Human Insulin and Analogues Market Share (%), 2010
Figure 4.2 The Leading Products in The Human Insulin and Analogues Market Sales ($bn), 2010
Figure 4.3 The Insulin Pump Market Share (%) by Region, 2010
Figure 4.4 The Insulin Pump Market Sales ($m) by Region, 2010
Figure 4.5 The Insulin Pump Market Forecast ($bn), 2010-2016
Figure 4.6 The Insulin Pump Market Forecast ($bn), 2010-2016
Figure 4.7 The Insulin Pump Market Forecast ($bn), 2016-2022
Figure 4.8 The Insulin Pump Market Forecast ($bn), 2016-2022
Figure 5.1 The Enteral Feeding Pump Market Share (%) by Region, 2010
Figure 5.2 The Enteral Feeding Pump Market Sales ($m) by Region, 2010
Figure 5.3 The Enteral Feeding Pump Market Sales Forecast ($bn), 2010-2016
Figure 5.4 The Enteral Feeding Pump Market Sales Forecast ($bn), 2010-2016
Figure 5.5 The Global Enteral Feeding Pump Market Forecast ($bn), 2016-2022
Figure 5.6 The Global Enteral Feeding Pump Market Forecast ($bn), 2016-2022
Figure 6.1 The Other Infusion Pumps Market Share (%) by Region, 2010
Figure 6.2 The Other Infusion Pumps Market ($bn) by Region, 2010
Figure 6.3 The Other Pump Market Sales Forecast ($bn), 2010-2022
Figure 6.4 The Top Nine Leading Cancer Drugs Sales ($bn), 2009 and 2010
Figure 6.5 Market Share (%) of Leading Cancer Drugs, 2009
Figure 6.6 Market Share (%) of Leading Cancer Drugs, 2010
Figure 6.7 The Global Narcotics Market Sales Forecast ($bn), 2010-2022
Figure 7.1 The Drug Delivery Market Share (%) by Segment, 2010
Figure 7.2 The Drug Delivery Market Sales ($bn) by Segment, 2010
Figure 7.3 The Drug Delivery Technology Market Share (%) by Country, 2010
Figure 7.4 The Drug Delivery Technology Market Sales ($bn) by Country, 2010
Figure 7.5 The Total Drug Delivery Technology Market Forecast ($bn), 2010-2022
Figure 7.6 The Drug Delivery Technology Market Forecast ($bn) by Segment, 2010-2022
Figure 8.1 The Total Average Annual Costs for the Available Insulin Delivery Technologies, 2010
Figure 8.2 The Chinese and Indian Infusion Pump Market Forecast ($bn), 2010-2022
Figure 9.1 The Global Infusion Pump Market ($bn) in 2010, 2016 and 2022
Figure 9.2 The Global Infusion Pump Market ($bn) by Region in 2010, 2016 and 2022
Figure 9.3 The Infusion Pump Market Forecast ($bn) by Segment, 2010, 2016 and 2022
Companies Listed
Abbott Laboratories
Abbott Nutrition
AcelRX
Acura Pharmaceuticals
Alcare Inc
ALCOR Scientific
Alkemes
Animas Corporation
Aradigm
ART Healthcare
Asante Solution
AstraZeneca
B.Braun
Baxter
BioDelivery Sciences
Boston University
Calibra Medical
Cambridge University
Cardinal Health
CareFusion Corporation
Celegene
Cellnovo
Center for Devices and Radiological Health (CDRH)
CeQur
China Aoxing
Codman & Shurtleff Inc
Covidien
D Medical Industries
Danone
Debiotech
DePuy
Diagnostic Systems
Disetronic
Dorn Veterans Administration Medical Center
DURECT
Eli Lilly
Emisphere
FDA
FDA MedWatch
Fresenius Kabi
Generex Biotechnology Corporation
GlaxoSmithKline (GSK)
Glycologic
Hospira
IBM
Insulet
Intercell
Johnson and Johnson (J&J)
Juvenile Diabetes Research Foundation (JDRF)
King Pharmaceuticals
MEDINGO Ltd
Medtronic
Micrus Endovascular
Moog
Nestle Healthcare
NiliMEDIX
Nipro Diagnostics
Novartis
Noven Pharmaceuticals
Novo Nordisk
Nutricia
Oregon Health & Science University
OST Medical
Pacira Pharmaceuticals
Pain Therapeutics
PAION
Pfizer
Pharmaco-Kinesis Corporation
pSivida Corporation
Purdue Pharma
Q Core Medical
QRx Pharmaceuticals
Roche
Roche Diagnostics
Sanofi-Aventis
Sansum Diabetes Research Institute
Shire Pharmaceuticals
SIGMA Spectrum
Smith Group Plc
Smith Medical
SOOIL
Spring
ST Microelectronics
Stanford University
Summit Medical Products
Takeda
Tandem Diabetes Care
Titan Pharmaceuticals
Valeritas
Vectura
WalkMed Infusion
To order this report:
Drug Delivery Technology Industry: Infusion Pumps: Technology and Market 2012-2022
Check our Industry Analysis and Insights
CONTACT
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article